Madam Chair, the changes to the PMPRB are going forward. We agree with the member opposite that we must have lower drug costs for Canadians. There is no point in having access to drugs that are unavailable because they are priced out of the market for most Canadians. The PMPRB is doing the work it needs to do, and we are very proud of our work to lower drug costs for Canadians.
In the House of Commons on November 26th, 2020. See this statement in context.